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OBJECTIVES The purpose of this study was to evaluate the accuracy of electrocardiogram (ECG)-gated
single-photon emission computed tomography (SPECT) for assessment of left ventricular
(LV) end-diastolic volume (EDV), end-systolic volume (ESV) and ejection fraction (EF)
compared with the gold standard of cardiac magnetic resonance imaging (MRI).
BACKGROUND Several comparisons of ECG-gated SPECT with cardiac MRI have been performed for
evaluation of LV volumes and EF, but each has considered few subjects, thus leaving
uncertainty about the frequency of discrepancies between the two methods.
METHODS We performed a meta-analysis of data on 164 subjects from nine studies comparing
ECG-gated SPECT versus cardiac MRI. Data were pooled in correlation and regression
analyses relating ECG-gated SPECT and cardiac MRI measurements. The frequency of
discrepancies of at least 30 ml in EDV, 20 ml in ESV and 5% or 10% in EF and concordance
for EF 40% versus 40% were determined.
RESULTS There was an overall excellent correlation between ECG-gated SPECT and cardiac MRI for
EDV (r  0.89), ESV (r  0.92) and EF (r  0.87). However, rates of discrepancies for
individual subjects were considerable (37% [95% confidence interval {CI}, 26% to 50%] for
at least 30 ml in EDV; 35% [95% CI, 23% to 49%] for at least 20 ml in ESV; 52% [95% CI,
37% to 63%] for at least 5% in EF; and 23% [95% CI, 11% to 42%] for at least 10% in EF).
The misclassification rate for the 40% EF cutoff was 11%.
CONCLUSIONS Electrocardiogram-gated SPECT measurements of EDV, ESV and EF show high correla-
tion with cardiac MRI measurements, but substantial errors may occur in individual patients.
Electrocardiogram-gated SPECT offers useful functional information, but cardiac MRI
should be used when accurate measurement is required. (J Am Coll Cardiol 2002;39:
2059–68) © 2002 by the American College of Cardiology Foundation
Electrocardiogram (ECG)-gated single-photon emission
computed tomography (SPECT), primarily using
technetium-99m, is advocated as an imaging technique that
can offer valuable information in the assessment of both
myocardial perfusion and ventricular function. While the
value of ECG-gated SPECT in assessing myocardial per-
fusion is undisputed (1,2), there are fewer data on the
accuracy of ECG-gated SPECT for estimating left ventric-
ular (LV) volumes and ejection fraction (EF). Cardiac
magnetic resonance imaging (MRI) is currently considered
the gold standard for these evaluations (3,4). Although
studies evaluating the performance of ECG-gated SPECT
versus cardiac MRI have suggested a good concordance of
the two methods (5–14), each study has included few
patients. Generalizations and broader inferences are difficult
from isolated investigations. It is also difficult to assess from
isolated studies whether the comparative accuracy of ECG-
gated SPECT differs in various patient subgroups. To
address these issues, we performed a meta-analysis of all
available data comparing ECG-gated SPECT versus car-
diac MRI. A patient-level meta-analysis approach enhanced
the power of detecting differences between the two methods
and maximized accuracy in estimating their magnitude.
METHODS
Eligibility criteria and search strategy. We considered
studies evaluating LV volumes (end-systolic volume [ESV]
and end-diastolic volume [EDV]) and EF by ECG-gated
SPECT (using technetium-99m-labeled sestamibi or tetro-
fosmin or thallium-201) as well as by cardiac MRI in the
same subjects. Data were eligible regardless of whether they
referred to healthy subjects or patients with suspected or
proven disease, and regardless of whether ECG-gated
SPECT images were acquired at rest or after stress. Data
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were also eligible regardless of the technical parameters used
for either test and regardless of the algorithm used for LV
volumes and EF calculations. Phantom-only and animal
studies were excluded.
We identified eligible studies by searching MEDLINE
and EMBASE (last search updated December 2001). The
search combined the terms “gated,” “SPECT,” “technetium”
or “Tc-99m,” “tetrofosmin,” “sestamibi,” “thallium” or “Tl-
201” and “magnetic resonance imaging,” “MRI” and “ejec-
tion fraction.” In addition, we perused bibliographies of
retrieved articles and reviews and communicated with ex-
perts in the field. Meeting abstracts were excluded because
they would not provide individual patient data and their
results might not be final.
The retrieved studies were carefully examined to exclude
duplication or overlap of subjects. Duplicate/overlapping
data were counted only once in the meta-analysis.
Data extraction. The following information was extracted
from each pertinent study: first author, year of publication
and journal; study population characteristics including gen-
der, mean age (and standard deviation), clinical setting,
selection of subjects (consecutive vs. other), study design
(prospective vs. retrospective or unspecified), inclusion and
exclusion criteria; relative timing of the two imaging pro-
cedures; technical characteristics of the ECG-gated SPECT
and the cardiac MRI; blinding of evaluators of one test to
the results of the other and to the clinical condition of the
tested subject; total number of subjects in the study; number
of subjects evaluated with either test and reasons for
nonevaluations; quantitative or qualitative assessment of
regional thickening; and percentage of subjects with history
of myocardial infarction and median EF by cardiac MRI.
The two latter parameters were used to characterize the
clinical background and average severity of LV dysfunction
in the studied population. For each subject, we recorded the
EDV, ESV and EF with each imaging modality. Whenever
numerical data were not given directly, we extracted the
relevant data using scanned computerized images of the
pertinent scatter plots and by communication with the study
investigators. When ECG-gated SPECT measurements
had been corrected by a phantom-study correction factor,
Abbreviations and Acronyms
CAD  coronary artery disease
CI  confidence interval
ECG  electrocardiogram
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
LV  left ventricle/ventricular
MRI  magnetic resonance imaging
SEE  standard error of estimate
SPECT  single-photon emission computed tomography
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analysis was performed both with uncorrected and corrected
values.
Data extraction was performed in duplicate by two
independent investigators. Discrepancies were solved by
consensus and by using a third investigator as arbitrator. We
verified that regression analyses from the data of each study
replicated the regression coefficients provided in the respec-
tive published report, typically within 1%.
Data synthesis. CORRELATION AND REGRESSION ANALYSES.
Each identified study had evaluated relatively few subjects.
Therefore, the main analysis involved pooling of individual
subject data across studies. Scatter plots were generated with
ECG-gated SPECT measurements on the y axis and
cardiac MRI measurements on the x axis. Pearson correla-
tion coefficients (r) were estimated, and a linear regression
was fit to each set of the ECG-gated SPECT versus cardiac
MRI data with unweighted least squares estimation for
intercept and slope coefficients and 95% confidence intervals
(CI). Coefficients of determination (R2) and standard errors
of the estimate (SEE) were calculated for each regression.
We also estimated correlation coefficients and regression
slopes for individual studies and examined whether the
regression slopes are significantly heterogeneous. Bland-
Altman plots and regressions examined whether the differ-
ence in the two measurements varied at different levels of
EDV, ESV or EF (15).
FREQUENCY OF DISCREPANCIES AND SUBGROUP ANALYSES.
We evaluated the proportion of cases and 95% CI for
differences of 30 ml in the EDV, 20 ml in the ESV and
5% or 10% in the EF between the two methods. The
cutoffs were defined a priori and reflect discrepancies that
are likely to be meaningful in situations where substantial
accuracy is needed for ventricular volumes and EF. We used
both simple pooling and weighted random effects modeling
to estimate the overall proportions and 95% CI of differ-
ences exceeding the specified cutoffs (16). Between-study
heterogeneity was assessed using exact inference for n*2
tables, where n is the number of studies. In the presence of
significant heterogeneity, the random effects estimates pro-
vide wider CI than simple pooling because they incorporate
an estimate of the between-study variance in the calcula-
tions. Thus, random effects are preferable when significant
heterogeneity is present.
Separate analyses were performed for subgroups defined
on the basis of low EF (40% by ECG-gated SPECT)
versus normal/intermediate EF, normal versus low ESV
(70 ml cutoff by ECG-gated SPECT) and blinding param-
eters. The cutoff EF of 40% is often used clinically to
differentiate between mild and significant systolic dysfunc-
tion. Selection for the ESV cutoff was based on prognostic
data for coronary artery disease (CAD) reported by Sharir et
al. (17). We did not use an EDV cutoff, as adjustments for
body surface area would be important, but such data were
not available. Subgroups were compared to evaluate whether
they differed in the concordance of the two methods asTa
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expressed by the metrics previously described. In the pre-
sented analyses, subgroup estimates are obtained with pool-
ing of the pertinent subjects across the eligible studies, but
random effects yielded similar estimates (not shown).
EXTENT OF MISCLASSIFICATION. Finally, we evaluated the
sensitivity and specificity and overall misclassification rate of
ECG-gated SPECT measurements in terms of classifying
subjects as having EF 40% versus 40%. Sensitivity and
Figure 1. Scatter plots of cardiac magnetic resonance imaging (MRI) and electrocardiogram (ECG)-gated single-photon emission computed tomography
(SPECT) measurements in subjects who underwent imaging with both modalities. (A) Left ventricular (LV) end-diastolic volume (EDV) in ml; (B) LV
end-systolic volume (ESV) in ml; (C) LV ejection fraction (EF). Patients in the two publications by Tadamura et al. (10,11) are shown as belonging to
the same study. End-diastolic volume and ESV data were not provided for individual subjects in Stolfuss et al. (8) and could only be discerned for subjects
with substantial discrepancies between cardiac MRI and ECG-gated SPECT in Mochizuki et al. (6) (not shown here, but included in the calculations of
the proportion with discrepancies). Faber pertains to reference 9, while FaberB pertains to reference 14.
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specificity values were estimated separately for each study
and synthesized by simple pooling and by random effects
across studies. Random effects independent synthesis of
sensitivity and specificity may tend to underestimate both
parameters (18), but a formal summary operating charac-
teristic curve approach (18) was not particularly helpful for
these data because the studies tended to operate in the same
area of the curve.
SOFTWARE. Analyses were performed in Advanced SPSS
10.0 (SPSS, Inc., Chicago, Illinois), Meta-Analyst (Joseph
Lau, Boston, Massachusetts), Meta-Test (Joseph Lau) and
StatXact3 (Cytel, Inc., Boston, Massachusetts). All p values
are two-tailed.
RESULTS
Eligibility of studies and extraction of individual patient
data. Thirteen potentially eligible reports were considered
(5–14,19–21). Of those, three were excluded because in two
studies there was no assessment of volumes (19,20), and one
study was performed on experimental animals (21). Two of
the remaining publications (5,8) pertained to the same
study, and all subjects in one publication were included in
the larger dataset of the earlier report; only the earlier report
was considered. Another team (10,11) had also published
two reports, and 13 of the 16 subjects in one report were
included among the 20 subjects of the other report; in the
meta-analysis, we considered the 20 subjects of the latter
report and the three additional nonoverlapping subjects
from the smaller study. In all, information on 164 subjects
who had both ECG-gated SPECT and cardiac MRI was
analyzed (Table 1).
Characteristics of subjects and of studies. In most stud-
ies, all patients who underwent cardiac MRI also had
ECG-gated SPECT and vice versa. However, there were
some exceptions (6,9,14). The study population was defined
with different criteria across studies, but usually patients had
a clinical indication for ECG-gated SPECT, typically
related to CAD. Stolfluss et al. (8) also included five healthy
subjects. Men accounted for 67% to 95% of each study’s
population, and the mean age was characteristic of CAD
patients. The proportion of subjects with prior myocardial
infarction varied from 42% to 100%, and median EF (by
cardiac MRI) ranged between 27% and 65% across studies.
Information on the number of segments with absent counts
that could not be assessed and on the number of severe
defects (photon counts 70% of maximal, absent counts or
qualitatively characterized as severe defects) were provided
only in two studies (8,11). The time interval between
ECG-gated SPECT and cardiac MRI was consistently 1
week in six studies. Three studies (6,12,13) allowed also
larger time windows but assured that patients were clinically
stable in the interim. Blinded interpretation was not con-
sistently used in all studies (Table 1).
All studies had used Tc-99m sestamibi or tetrofosmin.
One study (10) also performed imaging with Tl-201 (in the
same study population as for Tc-99m imaging). Concor-
dance of ECG-gated SPECT with cardiac MRI was fairly
similar in the Tc-99m and Tl-201 evaluations. All the
reported calculations in the meta-analysis use only the
Figure 1. Continued.
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Tc-99m data. All studies used rest acquisitions, except for
one investigation with 30 patients (14) and 6 of the 21
patients in another study (13). For volumetric MRI mea-
surements, all but one (6) study used the disk-area method
(Simpson’s rule). For ECG-gated SPECT measurements,
the majority of the studies used an automated quantitative
software package (22). Geometrical modeling of the LV
based on a single (23) or multiple ventricular dimensions
was also used. One study used two different automatic
methods of computation of the LV parameters (14), quan-
Figure 2. Bland-Altman plots of the data presented in Figure 1. (A) Left ventricular (LV) end-diastolic volume (EDV) in ml; (B) LV end-systolic volume
(ESV) in ml; (C) LV ejection fraction (EF).
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titative gated SPECT and Emory cardiac toolbox. The first
one is used in the main data synthesis because it is more
commonly used. Sensitivity analyses using the data obtained
with the other method yielded largely similar results (not
shown). Other technical characteristics are shown in Table 2.
Pooled analyses. Overall, there was very good correlation
between the ECG-gated SPECT and cardiac MRI mea-
surements (correlation coefficients, 0.89 for EDV, 0.92 for
ESV, 0.87 for EF; p  0.001 for all) (Fig. 1). The
correlation was also excellent when limited to studies with
all measurements obtained at rest (correlation coefficients,
0.92 for EDV, 0.94 for ESV, 0.90 for EF; p  0.001). The
best-fit regression lines in the pooled analyses for predicting
the ECG-gated SPECT values as a function of the cardiac
MRI values were as follows: y 0.84x 14 for EDV (SEE
 34); y  0.87x  12 for ESV (SEE  26) and y  0.83x
 5.2% for the EF (SEE  7.8). The R2 values were 0.80,
0.85 and 0.75, respectively. The regressions suggest that
ECG-gated SPECT tends to overestimate EDV and ESV
compared with cardiac MRI for values 89 ml, while it
tends to overestimate EDV and ESV at higher volumes.
The expected ESV difference is 1 ml at ESV 100 ml. The
expected EDV difference is 18 ml at EDV  200 ml. On
average, ECG-gated SPECT tends to overestimate EF
when EF is very low (31%), while it tends to underesti-
mate EF when ventricular function is preserved. The
expected difference is 5% at EF 60%. Results were similar
when phantom-study corrections were used for one study
(10,11).
Correlation coefficients were consistently high in all
included studies (range: 0.81 to 0.97 for EDV; 0.87 to 0.99
for ESV; 0.72 to 0.93 for EF). However, there was
variability in the regression slopes (range: 0.76 to 1.28 for
EDV; 0.79 to 1.29 for ESV; 0.65 to 1.10 for EF).
Variability in EDV and ESV was largely accounted by the
low slopes obtained for the Tadamura et al. (10,11) data (it
was substantially reduced when volumes in this study were
corrected with a phantom-correction). Variability in EF was
largely accounted by the low slope in Faber et al. (14),
regardless of the automatic method used for SPECT vol-
ume calculation.
The difference between the ECG-gated SPECT and
cardiac MRI measurements did not vary substantially at
different levels of LV EDV or EF (Fig. 2A and 2C).
However, there was a suggestion that for ESV the average
difference between the ECG-gated SPECT and cardiac
MRI measurements was greater at larger ESV values (p 
0.070) (Fig. 2B).
Discrepancies between ECG-gated SPECT and cardiac
MRI. Despite an overall excellent correlation, considerable
discrepancies between the ECG-gated SPECT and cardiac
MRI measurements were common for individual subjects
(Table 3). There was substantial heterogeneity in the rates
of large discrepancies between the included studies, in
particular for EF; therefore, weighted random effects calcu-
lations are more appropriate than pooling. By random
effects, the percentage of large discrepancies was 37% (95%
CI, 26% to 50%) for 30 ml in EDV, 35% (95% CI, 23%
to 49%) for20 ml in ESV, 52% (95% CI, 37% to 63%) for
5% in EF and 23% (95% CI, 11% to 42%) for 10% in
EF.
Figure 2. Continued.
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Subgroup analyses. The frequency of large discrepancies
was slightly less common in subjects where the ECG-gated
SPECT EF was 40% than in those with larger ECG-
gated SPECT EF estimates, but the difference was not
formally significant. The cardiac MRI EF differed by at
least 10% in 12/67 and 28/97 subjects in the two subgroups,
respectively (p  0.10). For differences of 5%, the respec-
tive proportions were 31/67 versus 53/97 (p  0.29).
Large discrepancies in the ESV estimates were signifi-
cantly more common in subjects with SPECT-estimated
ESV of 70 ml than those with SPECT-estimated ESV of
70 ml. The rates of discrepancies of 20 ml were 12/73
(16%) versus 37/64 (58%) in the two subgroups respectively
(p  0.001). When the cutoff of 70 ml was based on the
cardiac MRI measurements, the results were similar (dis-
crepancy rates 15/78 [19%] vs. 34/59 [58%], respectively, p
 0.001).
Finally, the results of four studies where each test had
been interpreted blinded to the results of the other did not
differ from the results of studies where this was not assured.
Similarly, blinding to clinical data did not affect the fre-
quency of discrepancies (not shown).
Misclassification. The ability of ECG-gated SPECT in
identifying subjects with an EF of 40% using the MRI as
the gold standard was very good across studies. Sensitivity
ranged between 50% and 100% across studies; specificity
estimates ranged between 75% and 100%. By simple pool-
ing, SPECT correctly diagnosed EF 40% in 53 of 58
subjects (sensitivity 91% [95% CI, 80% to 97%]) and
correctly found EF 40% in 93 of 106 subjects (specificity
88% [95% CI, 80% to 93%]). Thus, 18 of 164 subjects were
misclassified (11%). Random effects calculations estimated a
sensitivity of 83% (95% CI, 69% to 92%) and specificity of
84% (95% CI, 75% to 90%), respectively.
DISCUSSION
Electrocardiogram-gated SPECT is the most commonly
employed technique for simultaneous assessment of LV
perfusion and function. Compared with nongated SPECT
acquisitions, ECG-gated approaches are better for defining
perfusion defects and assessing regional wall motion. They
may have particular utility for evaluation of women (24),
differentiation of etiology of cardiomyopathy (25) and
overall assessment of viability (5,26,27). The measurement
of LV EF and volumes with ECG-gated SPECT can be
obtained at no additional exposure to radiation, cost or
patient discomfort. Information regarding EF and volumes
has important prognostic implications in patients with
known or suspected CAD (17,28). Automated, reproduc-
ible algorithms for LV EF and volume data remove subjec-
tivity from these measurements.
Electrocardiogram-gated SPECT has been tested in
several small studies with phantom experiments, animal
studies and patient series. However, small series may suffer
from large statistical uncertainty and may apply only to
specific, selected patient populations. In this meta-analysis
we have tried to evaluate on a broader scale the clinical utility
of ECG-gated SPECT for measurement of LV EF and
volumes. We found a very high correlation between ECG-
gated SPECT and cardiac MRI measurements. On average,
the two imaging modalities show very good concordance.
However, we also found that for measurements on individual
subjects, the likelihood of substantial error is considerable.
Per our estimates, half of the ECG-gated SPECT EF
determinations may deviate by at least 5% from the cardiac
MRI-obtained values, and one of four may deviate by 10%
or more. Substantial errors in EDV and ESV calculations
are common, and for ESV the average deviation between
the two imaging modalities tended to increase with larger
Table 3. Proportion of Differences Between ECG-Gated SPECT and Cardiac MRI
Measurements
Study
Subjects With Difference (%)
>30 ml in EDV >20 ml in ESV >5% in EF >10% in EF
Mochizuki et al. (6) 5/18 (28) 4/18 (22) 8/18 (44) 0/18 (0)
Vaduganathan et al. (7) 4/17 (24) 7/17 (41) 14/17 (82) 11/17 (65)
Stolfuss et al. (8) ND ND 10/26 (38) 5/26 (19)
Faber et al. (9) 4/7 (57) 1/7 (14) 5/7 (72) 1/7 (14)
Tadamura et al. (10,11) 28/23 (35) 4/23 (17) 9/23 (39) 2/23 (9)
Bax et al. (12) 12/22 (55) 14/22 (64) 5/22 (23) 0/22 (0)
Bavelaar-Croon et al. (13) 11/21 (52) 7/21 (33) 11/21 (52) 7/21 (33)
Faber et al. (14) 6/29 (21) 12/29 (41) 22/30 (73) 14/30 (47)
Total, sum 50/137 (36) 49/137 (36) 84/164 (51) 40/164 (24)
Heterogeneity
p value 0.07 0.03 0.0006  0.0001
Faber et al. (14) estimates are based on the QGS (Quantitative Gated SPECT) program data; the respective rates for Emory
Cardiac Toolbox data are 15/29, 9/29, 17/30 and 8/30, respectively. End-systolic volume and EDV data for MRI are missing
in one patient from Faber et al. (14).
ECG  electrocardiogram; EDV  end-diastolic volume; EF  ejection fraction; ESV  end-systolic volume; MRI 
magnetic resonance imaging; ND  no data; SPECT  single-photon emission computed tomography.
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LV ESV values. One in nine subjects would be judged by
ECG-gated SPECT to be in the wrong category of LV
function, when EF must be categorized as being 40% or
40%. Thus, ECG-gated SPECT may not be reliable for
determination of LV volumes and EF when large accuracy
is required, such as in patients with cardiomyopathies, those
receiving cardiotoxic chemotherapy and those considered
for transplantation and in the evaluation of volumes for
clinical research studies.
Measurement error may be even larger in everyday
clinical practice. Images in the considered studies were
almost exclusively acquired at rest, while ECG-gated
SPECT acquisitions are typically performed after stress. In
patients with severe CAD, subendocardial perfusion may be
decreased, accounting for apparent LV cavity dilation
(29,30). For these patients, calculations of LV EF and
volumes may be inaccurate, yet these are the patients in
whom it would be most important to have accurate assess-
ments. Nevertheless, the one study that used exclusively
post-stress images (14) did not show different results from
the others. However, there were few patients with low EF in
that study, and more evidence should be accumulated in this
setting.
The meta-analysis suggests some areas where additional
research regarding the accuracy of ECG-gated SPECT for
assessment of LV volumes and EF would be warranted.
First, in patients with severe perfusion defects: in these
patients, severe reduction of photon counts in a myocardial
region (or absence of photon counts) may lead to underes-
timation of regional wall motion, due to inadequate visual-
ization (31). More data are needed on whether newer
approaches may overcome this limitation (32). Second, in
women: in all studies together, fewer than 30 women were
included. A smaller LV cavity in women may cause errors
related to partial volume averaging (33). Finally, more
experience is needed for Tl-201 imaging. One study sug-
gested good concordance between Tc-99m and Tl-201
imaging (10), but Tl-201 has been reported to have higher
variability than Tc-99m in studies that did not use cardiac
MRI for comparison (34,35).
In conclusion, ECG-gated SPECT correlates well with
cardiac MRI for measurement of LV volumes and EF.
However, on an individual patient level, significant errors
may occur and, thus, when accurate measurement is re-
quired, cardiac MRI is recommended.
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